目的探讨欧洲胃肠和腹部放射学会(European Society of Gastrointestinal and Abdominal Radiology,ESGAR)和欧洲儿科放射学会(European Society of Paediatric Radiology,ESPR)肠道MR技术推荐中,肠道充盈规范在胃肠道肿瘤术后患者中应...目的探讨欧洲胃肠和腹部放射学会(European Society of Gastrointestinal and Abdominal Radiology,ESGAR)和欧洲儿科放射学会(European Society of Paediatric Radiology,ESPR)肠道MR技术推荐中,肠道充盈规范在胃肠道肿瘤术后患者中应用的可行性,并初步分析胃肠道手术对小肠充盈扩张的影响。材料与方法回顾性分析2017年3月至2019年3月行小肠MR成像检查的胃肠道肿瘤术后随访患者的连续资料,肠道准备参照ESGAR及ESPR技术推荐执行,记录摄入对比剂体积。根据患者的手术史,将完成1500 mL推荐剂量摄取的受试者分为胃肿瘤术后组、小肠肿瘤术后组、结直肠肿瘤术后组。由两位医师分别在冠状位T2图像上测量十二指肠、空肠(近端及远端)、回肠(近端及远端)肠道直径,并按4分法评分,图像质量按3分法评分。采用Kruskal-Wallis H检验比较胃肿瘤术后组、小肠肿瘤术后组、结直肠肿瘤术后组的各肠段评分及图像质量评分。结果十二指肠、远端空肠、近端回肠、远端回肠的肠道充盈评分在胃肿瘤术后组、小肠肿瘤术后组和结直肠肿瘤术后组之间差异均无统计学意义(P>0.05);胃肿瘤术后组的近端空肠肠道充盈评分优于小肠肿瘤术后组,两组差异有统计学意义(调整后P<0.05);结直肠肿瘤术后组的近端空肠肠道充盈评分优于小肠肿瘤术后组(调整后P<0.05)。结论采用ESGAR和ESPR技术推荐对胃肠道肿瘤术后患者进行小肠MR成像随访,可以得到有良好图像质量且满足临床诊断要求的MR图像。除近端空肠外,胃肠道手术对于小肠充盈扩张无显著影响。展开更多
目的探讨欧洲胃肠和腹部放射学会(European Society of Gastrointestinal and Abdominal Radiology,ESGAR)和欧洲儿科放射学会(European Society of Paediatric Radiology,ESPR)肠道MRI推荐联合共识中肠道充盈在低体质量指数(body mass ...目的探讨欧洲胃肠和腹部放射学会(European Society of Gastrointestinal and Abdominal Radiology,ESGAR)和欧洲儿科放射学会(European Society of Paediatric Radiology,ESPR)肠道MRI推荐联合共识中肠道充盈在低体质量指数(body mass index,BMI)患者的可行性及技术要点。材料与方法回顾分析2017年11月1日至2018年12月31日期间因怀疑有小肠疾病而行小肠MRI检查的连续患者资料,肠道准备参照ESGAR及ESPR技术推荐执行,纳入无胃肠道手术的受试者进一步分析。记录受试者身高、体重及BMI值并分组(低BMI组、正常BMI组及高BMI组),记录摄入对比剂容积(正常摄取量组1200~1500 mL;低摄取量组1000~1200 mL)。由两位医师分别测量十二指肠、空肠(近端及远端)、回肠(近端及远端)直径,并按4分法评分。采用K-W检验比较不同BMI组之间各段肠道充盈评分差异有无统计学意义。进一步比较低BMI组中,低摄取量组与正常摄取量组各段肠道充盈评分差异有无统计学意义。结果受试者中,低BMI组均值为(16.8±1.2)kg/m2,正常BMI组为(21.3±1.6)kg/m2,高BMI组为(27.2±5.4)kg/m2。各BMI组两两间肠段充盈评分(总分及分段评分)无显著性差异(P>0.05);低BMI组中低摄取量组与正常摄取量组各肠段充盈评分无显著性差异(P>0.05)。结论不同BMI组应用ESGAR和ESPR技术推荐均可行,各肠道充盈评分差异无统计学意义。低BMI组中,对比剂低摄取量(1000~1200 mL)组与正常摄取量(1200~1500 mL)组的肠道充盈评分差异无统计学意义。展开更多
Chilaiditi syndrome is the interposition of the colon between the diaphragma and the liver. In general, patients are asymptomatic, but some patients have been associated with gastrointestinal and respiratory symptoms....Chilaiditi syndrome is the interposition of the colon between the diaphragma and the liver. In general, patients are asymptomatic, but some patients have been associated with gastrointestinal and respiratory symptoms. A 5- month- old infant boy was admitted to the hospital with a history of cough, cyanosis and recurrent respiratory distress that had persisted during the preceding 2 months. The chest X- ray revealed an elevation of the right hemidiaphragma caused by the presence of a dilated colonic loop below. Computed tomography showed a hepatodiaphragmatic interposition of the colon, leading to the diagnosis of Chilaiditi syndrome. The patient was conservatively treated with oxygen, fluid supplementation and stool softeners. We conclude that this rare syndrome should be kept in mind when young patients present with recurrent respiratory distress.展开更多
文摘目的探讨欧洲胃肠和腹部放射学会(European Society of Gastrointestinal and Abdominal Radiology,ESGAR)和欧洲儿科放射学会(European Society of Paediatric Radiology,ESPR)肠道MR技术推荐中,肠道充盈规范在胃肠道肿瘤术后患者中应用的可行性,并初步分析胃肠道手术对小肠充盈扩张的影响。材料与方法回顾性分析2017年3月至2019年3月行小肠MR成像检查的胃肠道肿瘤术后随访患者的连续资料,肠道准备参照ESGAR及ESPR技术推荐执行,记录摄入对比剂体积。根据患者的手术史,将完成1500 mL推荐剂量摄取的受试者分为胃肿瘤术后组、小肠肿瘤术后组、结直肠肿瘤术后组。由两位医师分别在冠状位T2图像上测量十二指肠、空肠(近端及远端)、回肠(近端及远端)肠道直径,并按4分法评分,图像质量按3分法评分。采用Kruskal-Wallis H检验比较胃肿瘤术后组、小肠肿瘤术后组、结直肠肿瘤术后组的各肠段评分及图像质量评分。结果十二指肠、远端空肠、近端回肠、远端回肠的肠道充盈评分在胃肿瘤术后组、小肠肿瘤术后组和结直肠肿瘤术后组之间差异均无统计学意义(P>0.05);胃肿瘤术后组的近端空肠肠道充盈评分优于小肠肿瘤术后组,两组差异有统计学意义(调整后P<0.05);结直肠肿瘤术后组的近端空肠肠道充盈评分优于小肠肿瘤术后组(调整后P<0.05)。结论采用ESGAR和ESPR技术推荐对胃肠道肿瘤术后患者进行小肠MR成像随访,可以得到有良好图像质量且满足临床诊断要求的MR图像。除近端空肠外,胃肠道手术对于小肠充盈扩张无显著影响。
文摘目的探讨欧洲胃肠和腹部放射学会(European Society of Gastrointestinal and Abdominal Radiology,ESGAR)和欧洲儿科放射学会(European Society of Paediatric Radiology,ESPR)肠道MRI推荐联合共识中肠道充盈在低体质量指数(body mass index,BMI)患者的可行性及技术要点。材料与方法回顾分析2017年11月1日至2018年12月31日期间因怀疑有小肠疾病而行小肠MRI检查的连续患者资料,肠道准备参照ESGAR及ESPR技术推荐执行,纳入无胃肠道手术的受试者进一步分析。记录受试者身高、体重及BMI值并分组(低BMI组、正常BMI组及高BMI组),记录摄入对比剂容积(正常摄取量组1200~1500 mL;低摄取量组1000~1200 mL)。由两位医师分别测量十二指肠、空肠(近端及远端)、回肠(近端及远端)直径,并按4分法评分。采用K-W检验比较不同BMI组之间各段肠道充盈评分差异有无统计学意义。进一步比较低BMI组中,低摄取量组与正常摄取量组各段肠道充盈评分差异有无统计学意义。结果受试者中,低BMI组均值为(16.8±1.2)kg/m2,正常BMI组为(21.3±1.6)kg/m2,高BMI组为(27.2±5.4)kg/m2。各BMI组两两间肠段充盈评分(总分及分段评分)无显著性差异(P>0.05);低BMI组中低摄取量组与正常摄取量组各肠段充盈评分无显著性差异(P>0.05)。结论不同BMI组应用ESGAR和ESPR技术推荐均可行,各肠道充盈评分差异无统计学意义。低BMI组中,对比剂低摄取量(1000~1200 mL)组与正常摄取量(1200~1500 mL)组的肠道充盈评分差异无统计学意义。
文摘Chilaiditi syndrome is the interposition of the colon between the diaphragma and the liver. In general, patients are asymptomatic, but some patients have been associated with gastrointestinal and respiratory symptoms. A 5- month- old infant boy was admitted to the hospital with a history of cough, cyanosis and recurrent respiratory distress that had persisted during the preceding 2 months. The chest X- ray revealed an elevation of the right hemidiaphragma caused by the presence of a dilated colonic loop below. Computed tomography showed a hepatodiaphragmatic interposition of the colon, leading to the diagnosis of Chilaiditi syndrome. The patient was conservatively treated with oxygen, fluid supplementation and stool softeners. We conclude that this rare syndrome should be kept in mind when young patients present with recurrent respiratory distress.
